OMB
.report
Search
Prescription Drug Advertisements and Product Communications
ICR 202406-0910-002
OMB: 0910-0686
Federal Form Document
OMB.report
HHS/FDA
OMB 0910-0686
ICR 202406-0910-002
( )
⚠️ Notice: This information collection may be outdated. More recent filings for OMB 0910-0686 can be found here:
2025-01-07 - Revision of a currently approved collection
Forms and Documents
Document
Name
Status
83-C 0686 Rx drug advertising to add 3rd party communications GFI JUNE 2024.docx
Justification for No Material/Nonsubstantive Change
2024-06-08
RIN AG27 CCN 0686 Revision Fall 2023.docx
Supporting Statement A
2023-11-16
RIN AG27 2016-994-DirecttoConsumerFRIA-10-25-2023.docx
Supplementary Document
2023-11-14
IC Document Collections
IC ID
Document
Title
Status
263161
Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format
Unchanged
232749
IC recommended in FDA guidance
Other-Agency Guidance
Modified
196331
Prescription Drug Advertisements 3rd Party Disclosure
Unchanged
196327
Prescription Drug Advertisements Reporting
Unchanged
ICR Details
© 2025 OMB.report |
Privacy Policy